Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Pineapple Express Cannabis (PNXP) EBITDA (2018 - 2025)

Pineapple Express Cannabis' EBITDA history spans 8 years, with the latest figure at $20459.0 for Q4 2025.

  • For Q4 2025, EBITDA rose 1739.34% year-over-year to $20459.0; the TTM value through Oct 2025 reached -$638461.0, down 6993.22%, while the annual FY2025 figure was -$16857.0, 71.67% up from the prior year.
  • EBITDA for Q4 2025 was $20459.0 at Pineapple Express Cannabis, up from $16658.0 in the prior quarter.
  • Across five years, EBITDA topped out at $32795.0 in Q1 2021 and bottomed at -$659293.0 in Q2 2025.
  • The 5-year median for EBITDA is -$2865.5 (2023), against an average of -$37585.2.
  • The largest YoY upside for EBITDA was 1739.34% in 2025 against a maximum downside of 18132.66% in 2025.
  • A 5-year view of EBITDA shows it stood at -$1027.0 in 2021, then plummeted by 266.99% to -$3769.0 in 2022, then skyrocketed by 43.88% to -$2115.0 in 2023, then surged by 40.99% to -$1248.0 in 2024, then surged by 1739.34% to $20459.0 in 2025.
  • Per Business Quant, the three most recent readings for PNXP's EBITDA are $20459.0 (Q4 2025), $16658.0 (Q3 2025), and -$659293.0 (Q2 2025).